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of prematurity in Central Saudi ArabiaAbdullah G. Al-Otaibi, MD ⇑; Sultan S. Aldrees, MD; Ahmed A. Mousa, PhDAbstractPurpose: To assess the long term visual outcomes and refractive status of patients who underwent diode laser for threshold ret-
inopathy of prematurity (ROP) and to investigate the risk factors leading to poor visual outcomes.
Methods: Fifty-seven patients (114 eyes) with threshold ROP who underwent laser therapy were contacted for reassessment. A
chart review was performed for all patients to collect data on visual acuity, retinal status and strabismus. A favorable visual out-
come was defined as P20/160 (Snellen acuity) for young adults (cooperative patients), and PCSM for children (uncooperative
patients) while unfavorable visual outcome was defined as <20/160 or <CSM. Vision in uncooperative children was graded as cen-
tral, steady, maintain. Descriptive and inferential analyses were conducted. Chi2 and odds ratios were calculated whenever appro-
priate. A P value <0.05 was considered as statistically significant.
Results: The mean age at reassessment was 5.2 ± 2.5 years (range, 1–10 years) where 36 (63.2%) patients were males and 21
(36.8%) were females. Out Of the 114 laser treated eyes, 73 (64%) were myopic, with mean spherical equivalent (SE) of 6.69
(5.9), range (0.25 to 21) diaopters, 8 (7%) were emmetrope, while other 33 (29%) were hyperopic with mean SE of +2.43
(3.04), range (+0.25 to +17) diaopters. Strabismus was present in 31 patients (54.4%) of whom 81% (25/31) were esotropic. Retina
was found to be normal in 77.1% of the examined eyes, while the remaining eyes had either macular dragging or retinal detach-
ment. Almost 70% of the eyes with a normal retinal examination had favorable visual outcome. Thirteen (11.4%) eyes had zone 1
retinopathy, 83 (72.8%) eyes had zone 2 retinopathy and 2 (1.8%) eyes had zone 3 retinopathy. Vitreous hemorrhage was present
in 7 (6.1%) eyes prior to laser treatment. The relationship between final retinal status and visual outcome was statistically significant
(P < 0.0001). There was no statistically significant correlation between visual outcome and the zone of the retinopathy (P = 0.448).
Conclusion: The majority of patients who underwent diode laser therapy for threshold ROP had favorable anatomical and visual
outcomes. However, high refractive error and strabismus may be clinically the pertinent causes of visual impairment.
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Retinopathy of prematurity can lead to blindness in prema-
ture infants without timely treatment. Cryotherapy was the
original ablation produce for the retina but it has been super-
seded by laser photocoagulation. The advantage of laser
photocoagulation is the reduction of unfavorable structuralPeer review under responsibility
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modalities may include the use of anti-vascular endothelial
growth factor (Anti-VEGF) therapies.1 The outcomes of a
7 year study of underweight newborns (<2000 g at delivery)
indicate that 22.2% of premature infants had ROP.2
The (CRYO-ROP) study reported a 50% reduction in the
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300 A.G. Al-Otaibi et al.old disease3 with better functional and structural outcomes
compared with control eyes.4 Early treatment of pre-thresh-
old ROP significantly reduces unfavorable functional and
structural outcomes.3
The current study evaluated the long term visual outcomes
and refractive status in patients who underwent diode laser
therapy for threshold ROP and investigated the causes of
poor visual outcomes.Methods
The study cohort was comprised of 114 eyes of 57 consec-
utive patients who underwent diode laser treatment for ROP
at King Abdul Aziz University Hospital (KAUH), Riyadh, Saudi
Arabia. These patients were contacted for assessment. The
mean age of recruited patients was 5.2 ± 2.5 years (range,
1–10 years). The study was performed between July 2010
and Nov 2010, where premature infants who weighed less
than 2000 g of birth body weight or were less than 32 weeks
of gestational age were screened for ROP in the neonatal
intensive care unit by an ophthalmologist.
Patient charts of 145 patients, who were admitted to
KKUH from 1995–2010 and underwent diode laser therapy
for symmetrical threshold disease, were recruited. Data were
retrospectively collected from the medical records. Of the
145 patients, 88 were not included in the study due to paren-
tal refusal, insufficient contact data, travel, and death unre-
lated to eye diseases. The remaining 57 premature infants
were contacted and examined. The study was conducted
after approval from the ethics committee of the institution
and adheres to the tenets of the Declaration of Helsinki.
At first ophthalmic examination, high risk premature in-
fants were screened at a Post-natal age of 4–6 weeks with
indirect ophthalmoscope. The stage and severity of ROP
were classified according to the International Classification
of ROP.5 Follow up of retinal examination was performed
every 1–2 weeks until ROP regression, complete vasculogen-
esis of retina, or development of threshold ROP. Infants with
threshold eyes disease received diode laser photocoagula-
tion within 48 h of diagnosis. The setting of laser treatment
was 250–300 mW with a creamy-white laser intensity, using
a near confluence pattern placed to the retinal avascular zone
anterior to the fibro-vascular ridge.Structural assessment
Indirect ophthalmoscopy was performed to detect any
structural sequelae, including macular distortion or dragging,
macular folds, or tractional retinal detachment.Orthoptic assessment
A trained Orthoptist performed the orthoptic assessment
that included evaluation of ductions and versions cover/un-
cover testing, and alternate cover testing to detect the pres-
ence of manifest and latent strabismus. If a child presented
with manifest strabismus, then a prism cover test was used
to measure the angle of deviation at distance and near fixa-
tions. The presence or absence of strabismus was evaluated
as an indicator for the potentiality to get amblyopia as a
cause of visual deficit.Visual acuity
The best corrected visual acuity (BCVA) was determined
with Snellen optotype chart at 6 m. Central, steady, maintain
fixation (CSM) was used for children who are not able to per-
form optotype acuity (young or mentally disabled). Visual
acuity of 20/160 or better was considered a favorable visual
outcome, and worse than 20/160 was considered an unfavor-
able visual outcome.Refraction
Cycloplegic refraction was determined with retinoscopy or
an autorefractometer after installation of 1% cyclopentolate
hydrochloride. Refractive errors were converted into spheri-
cal equivalent. Myopia was divided into three categories
based on magnitude: severe (more than 6 D), mild (0.25–3
D) and moderate (>3–6 D).The refractive error of each eye
was evaluated. All study subjects were under the ongoing
care of a pediatric ophthalmologist.Statistical analysis
Data were collected and stored in an excel sheet (Micro-
soft Office 2007; Microsoft Corp., Redmond, WA, USA).
After data management, data were analyzed using SPSS ver-
sion 19 (IBM Corp., Armonk, NY, USA), and StatsDirect ver-
sion 6.1 (StatsDirect Ltd., Cheshire, UK). Descriptive
analysis included describing the sample in terms of demo-
graphic characteristics. Inferential analysis included the Chi2
test to investigate the relationship between categorical vari-
ables, while Odds Ratio was calculated to investigate the
association between ROP and potential risk factors. Confi-
dence intervals of 95% and a corresponding P < 0.05 were
considered statistically significant. An odds ratio that does
not include one was considered statistically significant.Results
The study cohort was comprised of 114 eyes of 57 patients
who underwent diode laser photocoagulation for symmetri-
cal threshold disease. Out of 57 patients, 36 (63.2%) were
males and 21 (36.8%) were females. In the majority of pa-
tients; 44 (77.2%) were of Saudi nationality. The mean
(±SD) birth weight at baseline was 896.9 ± 331.5 g, (range,
400–1800 g), and, the average gestational age was
26.5 ± 3.1 weeks (range, 21–41 weeks). The average duration
between onset of disease to presentation at a hospital and
diagnosis was 8.7 ± 3.8 months (range, 1–17 months). The
mean follow up period was 5.2 years (range, 1–10 years).Orthoptic results
In the majority of cases; 14 (42.4%) patients used their
right eye for fixation more than their left eye; 7 (21.2%) pa-
tients and there were 4 (12.1%) patients with alternating fix-
ation. Exotropia was present in 31(54.4%) patients with a
mean of 27 ± 8.4 prism diopter (pd) (range, 16–40 pd).
Esotropia was present in 25 (43.9%) patients with a mean
of 24.8 ± 14.6 pd (range, 3–50 pd). Nystagmus was present
in only 5 (8.8%) patients.
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The majority; 108 (94.6%) of eyes had a normal anterior
segment while 2 (1.8%) eyes had cataract and other 2
(1.8%) eyes had post-synechiae.Classification of the disease
Based on the international method of classification, a con-
siderably large number of eyes were affected in Zone II (83
(72.8%) eyes), followed by Zone I (13 (11.4%) eyes) and Zone
III (2 (1.8%) eyes). Additionally, 9 (7.9%) eyes were at the pre-
threshold stage, and 7 (6.1%) eyes had a vitreous
hemorrhage.Structural assessment of the retina
Funduscopy showed that 88 (77.1%) of the cases had a
normal retina, while 12 (10.5%) cases had macular dragging,
5 (4.4%) cases had retinal detachment, 7 (6.2%) cases had
pale optic disk, and 2 (1.8%) cases had end stage ROP.Visual outcomes
Twenty-eight patients (56 eyes) were cooperative for vi-
sual acuity testing who had a mean age of 6.8 ± 1.9 years,
(range, 3–10 years) constituted 49.1% of the study popula-
tion, 21.1% (24 eyes) of them had a visual acuity of P20/40
and 15 eyes (13.2%) had visual acuity in the range of 20/
50–20/160, 13 (11.4%) eyes had visual acuity 20/200 to light
perception and 4 (3.5%) eyes had no light perception.
Among the 29 uncooperative children (58 eyes) who could
not perform the Snellen acuity test, 45 (39.5%) eyes had
CSM, 6 (5.3%) eyes had CSUM, 2 (1.8%) eyes had CUSUM
and 5 (4.4%) eyes had UCUSUM.
A favorable visual outcome defined asP20/160 orPCSM
was noted in 84 (73.7%) eyes while unfavorable visual out-
come defined as <20/160 or <CSM was noted in 30
(26.3%) eyes (Table 1).Table 1. Visual acuity outcomes of patients who underwent diode laser
treatment for retinopathy of prematurity.
Cooperative patientsa N Percentage (%)
P20/40 24 21.1
20/50–20/160 15 13.2
20/200–LP 13 11.4
NLP 4 3.5
P20/40 24 21.1
20/50–20/160 15 13.2
20/200–LP 13 11.4
NLP 4 3.5
Uncooperative patientsb
CSM 45 39.5
CSUM 6 5.3
CUSUM 2 1.8
UCUSUM 5 4.4
Total Favorable P20/160 or PCSM 84 73.7
Total Unfavorable <20/160 or <CSM 30 26.3
a Cooperative patients were patients who could read Snellen letters during visual
acuity testing.
b Uncooperative patients were patients who were too young or otherwise unable to
perform the Snellen acuity CSM denotes central, steady, maintain.Refraction
Eight (7%) of the eyes were emmetropic. The majority of
eyes were myopic 73 (64%) with mean spherical equivalent
(SE) of 6.69 (5.9), range (0.25 to 21) diaopters, while
other 33 (29%) were hyperopic with mean SE of +2.43
(3.04), range (+0.25 to +17) diaopters. The mean spherical
equivalent of the study cohort was 3.7 ± 6.5 D. (Table 2).
There was a highly statistically significant association be-
tween the presence of a retinal abnormality at baseline and
an unfavorable visual outcome postoperatively (P < 0.0001).
There was no statistically significant association between
while the zone of the disease and sex of the patient were with
visual outcomes (P = 0.448 and 0.603, respectively).
Other statistically significant potential risk factors that may
lead to unfavorable visual outcomes were: gestational age
(P = 0.014) esotropia (P = 0.049) (P = 0.580) and presence
of refractive errors (P = 0.016).Discussion
Favorable functional and structural outcomes of laser trea-
ted ROP eyes compared with cryotherapy have been previ-
ously reported.6–9 However, the current study presents the
long term structural and visual outcomes of laser treated
threshold ROP with large cohort and a mean age of 5.2 years
(range, 1–10 years). According to Yang et al., many patients
with favorable structural outcomes suffered from impaired vi-
sual function on long term follow up.6 Yang et al. suggested
some variables that may contribute to the poor visual out-
comes including myopia, strabismus, prenatal neurologic
events and anisometropia which were significantly associated
with poor visual outcomes in ROP patients treated with laser
(P = 0.002).6
We found that 64% of our study cohort were myopic of
which 28.9% had more than 6.0 D of myopia. Yang et al.6 re-
ported similar that results with 77% of 60 eyes were myopic
of which16.7% had more than 6.0 D of myopia. Yang et al.6
reported a mean spherical equivalent of 3.87 D which was
clinically negligible from 3.7 ± 6.5 D in our study. McLoone
et al.7 also reported similar results with 50% of 43 eyes that
underwent laser therapy for ROP were myopic with 35% hav-
ing myopia greater than 4.0 D (Table 3). White and Repka
performed a 3 year follow up of and reported comparable
structural outcomes and better functional outcomes com-
pared to cryotherapy.8 In White and Repka’s study, the laser
treated group was myopic with a mean spherical equivalent
of 6.6 D.8 The difference between the outcomes of White
and Repka’s study and our study maybe partially related to
the differing sample size between both studies (57 patients
in our study vs 12 patients), although the mean follow upTable 2. Refractive errors of patients who underwent diode laser treatment
for retinopathy of prematurity.
Type of refraction Number Percentage (%)
Mild myopic 25 21.9
Moderate myopic 15 13.2
Severe myopic 33 28.9
Emmetrope 8 7
Mild hyperopic 22 19.3
Moderate hyperopic 9 7.9
Sever hyperopic 2 1.8
Table 3. Refractive outcomes reported in various studies of laser therapy
for retinopathy of prematurity.
Authors No. of
eyes
Laser Follow up
(years)
Mean spherical
equivalent
McLoone
et al.7
37 Diode 11 2.1 D
Ng et al.13 20 Argon and
diode
9.9 4.48 D
Opsina
et al.14
42 Argon 6.2 4.95 D
Yang
et al.6
60 Diode 7.8 3.87 D
Current
study
114 Diode 5.2 3.7 D
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most similar. Shalev et al.9 performed an extended follow
up of (7 years) and reported a minimal reduction of myopia
in the laser treated groups.
The association between myopia and ROP has been recog-
nized with an increase in the incidence among severe and low
birth weights. Various hypotheses have been proposed for the
cause of myopic fundi including; shallow AC, axial length and
high crystalline lens power.7,10,11 Tasman et al.12 proposed
that retinal detachment associated with myopic fundi is a pre-
dominant finding in retinopathy of prematurity.
The cryo-ROP study group reported visual acuity of 20/40
or better in 25.2% of the treated versus 23.71% of non trea-
ted eyes.15 Smaller comparative studies have found good vi-
sual outcomes in the group of eyes treated with laser.8,9 In
our study we have divided the patients into two groups
based on their visual acuity. Visual acuityP20/160 orPCSM
was achieved in 73.7% the study cohort indicating good func-
tional success of laser therapy.
More than half of the cohort (54.4%) had strabismus of
which 43.9% had esotropia. Esotropia is significantly associ-
ated with poor visual outcomes (P = 0.049) but not exotropia.
Yang et al.6 reported a 30% incidence of strabismus with more
than half of the cases were esotropic. Yang et al.6 also found
that most common concomitant conditions with strabismus
were perinatal neurological events (e.g. periventricular leuco-
malacia, intraventricular hemorrhage), anisometropia, high
myopia and unfavorable anatomical outcomes. The incidence
of strabismus increases by 34% in regressed ROP patients
compared to neonates without ROP (16%). Furthermore it
increases with the severity of ROP.16–18 Nystagmus was pres-
ent in a very few number of patients (8.8%) which was statisti-
cally insignificant in affecting visual outcomes. This outcome
concurs with a study by McLoone et al.7 who reported 12%
of 37 patients with nystagmus.
Almost 75% of our patients had favorable structural
outcomes, with only 22.9% having some sort of macular
cdragging, retinal detachment, pale optic disk and end stage
ROP. The correlation of abnormal retinal structure with poor
visual outcomes was statistically significant (P = 0.0001). Yang
et al.6 reported 1.7% of the treated eyes with abnormal reti-
nal structure, but 34.5% had unfavorable visual outcomes,
indicating other factors leading to poor visual outcome such
anisometropia, high myopia, nystagmus. McLoone et al.7 re-
ported 10 eyes with poor visual outcomes of which only three
had poor structural outcomes. Opsina et al.14 reported that
abnormal retinal structure rarely causes poor visual outcomes
after laser therapy for ROP compared to factors such as stra-
bismus, amblyopia and perinatal neurological events.Some potential limitations of our study included the retro-
spective analysis and the non- randomized study design in
addition to some data were missing from the patient charts.
The large sample size made detailed analysis of each individ-
ual case tenuous at best. Other drawbacks of the study were
that we did not assess some variables which are believed to
be associated with poor visual outcomes such as anisometro-
pia, astigmatism and perinatal neurological events. However,
the large sample size of our study population and long term
follow up is an advantage as it provides more accurate results
regarding the potential variables and their association with
the structural and visual outcomes.
Laser treatment for ROP can result in complications,
including corneal haze, iris and tunica vasculosa lentis, and
constricted visual field.19–25 In our study, 2% of the cohort
had cataract. However causation from laser therapy or other
factors remain inconclusive due to our study design.
In conclusion, the majority of patients with diode laser ther-
apy had favorable visual and structural outcomes. However
strabismus and high refractive errors remain the important
causes of impaired visual function. Early detection and timely
treatment reduce the associated morbidity. A special empha-
sis should be placed on early detection and treatment of ROP
to decrease the unfavorable outcomes of laser treated eyes.Reference
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